Author of the publication

Case-crossover study design in pharmacoepidemiology: systematic review and recommendations.

, , , , and . Pharmacoepidemiology and drug safety, 22 (11): 1146-53 (November 2013)7472<m:linebreak></m:linebreak>CI: Copyright (c) 2013; JID: 9208369; OTO: NOTNLM; 2012/12/18 received; 2013/06/20 revised; 2013/07/29 accepted; aheadofprint;<m:linebreak></m:linebreak> <m:linebreak></m:linebreak>Dissenys híbrids; Case-crossover.
DOI: 10.1002/pds.3508

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Case-crossover study design in pharmacoepidemiology: systematic review and recommendations., , , , and . Pharmacoepidemiology and drug safety, 22 (11): 1146-53 (November 2013)7472<m:linebreak></m:linebreak>CI: Copyright (c) 2013; JID: 9208369; OTO: NOTNLM; 2012/12/18 received; 2013/06/20 revised; 2013/07/29 accepted; aheadofprint;<m:linebreak></m:linebreak> <m:linebreak></m:linebreak>Dissenys híbrids; Case-crossover.Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs., , , , and . PLoS Comput. Biol., (2023)